REPORT ON OPERATIONS CONSOLIDATED FINANCIAL STATEMENTS STATUTORY FINANCIAL STATEMENTS OF SORIN SPA AT DECEMBER 31, 2012

Size: px
Start display at page:

Download "REPORT ON OPERATIONS CONSOLIDATED FINANCIAL STATEMENTS STATUTORY FINANCIAL STATEMENTS OF SORIN SPA AT DECEMBER 31, 2012"

Transcription

1 REPORT ON OPERATIONS CONSOLIDATED FINANCIAL STATEMENTS STATUTORY FINANCIAL STATEMENTS OF SORIN SPA AT DECEMBER 31, 2012 SORIN S.p.A. Registered and Administrative Offices: Tel.: Share Capital: 478,738,144 euros Milano Tax I.D. No Via Benigno Crespi, 17 VAT No Milan Company Register, REA No

2 Disclaimer This document contains forward-looking statements, particularly in the section entitled Business Outlook. By their very nature, forward-looking statements entail a certain degree of risk and uncertainty because they are predicated on the occurrence of future events and developments. Actual results could differ, even to a significant extent, from those projected, due to a number of factors, such as general macroeconomic conditions, changes in economic and regulatory framework in many of the countries where Sorin Group operates, success in developing and implementing new technologies and other changes in business conditions, including activities by the competition. 2 Sorin Group 2012 Annual Report

3 CONTENTS CORPORATE GOVERNANCE BODIES AND COMMITTEES... 4 SORIN GROUP... 6 SUSTAINABILITY INVESTOR RELATIONS CONSOLIDATED FINANCIAL HIGHLIGHT Foreword REPORT ON OPERATIONS AT DECEMBER 31, at a Glance A Letter to Shareholders Alternative Performance Indicators Operating Performance Operating Performance of the Main Group Companies Sorin Group s Operating and Financial Results Operating and Financial Results of Sorin S.p.A Research and Development Human Resources and Industrial Relations Intra-Group Transactions and Transactions with Related Parties Main Risks and Uncertainties to Which Sorin S.p.A. and the Group Are Exposed Report on Corporate Governance and the Company s Ownership Structure Compensation Report Significant Events Occurring After December 31, Business Outlook Motion to Approve the Financial Statements and Appropriate the 2012 Net Profit SORIN GROUP CONSOLIDATED FINANCIAL STATEMENTS AT DECEMBER 31, ANNEX (Pursuant Article 149-duodecies of the Consob s Issuer s Regulations) ATTESTATION OF THE CONSOLIDATED FINANCIAL STATEMENTS AT DECEMBER 31, 2012 PURSUANT TO ARTICLE 154 BIS OF LEGISLATIVE DECREE N. 58/ SORIN SPA STATUTORY FINANCIAL STATEMENTS AT DECEMBER 31, ANNEX (Pursuant Article 149-duodecies of the Consob s Issuer s Regulations) ATTESTATION OF THE STATUTORY FINANCIAL STATEMENTS AT DECEMBER 31, 2012 PURSUANT TO ARTICLE 154 BIS OF LEGISLATIVE DECREE N. 58/ REPORT OF THE BOARD OF STATUTORY AUDITORS REPORT OF THE INDEPENDENT AUDITORS Sorin Group 2012 Annual Report

4 CORPORATE GOVERNANCE BODIES AND COMMITTEES Board of Directors Chairman Deputy Chairman Chief Executive Officer Directors Rosario Bifulco Giovanni Pavese André-Michel Ballester Andrea Bovone Giuseppe Carteni (1) (3) Luciano Cattani (1) (3) Sergio Gianfranco Luigi Maria Dompé (1) (5) Roberto Ferri (1) (3) Laura Iris Ferro (1) (3) Roberto Giay (3) Ugo Ortelli (1) (3) Gino Santini (1) (3) Ugo Smiraglia (3) Maurizia Squinzi (3) Massimo Tononi Claudio Albertini (2) Giuliano Asperti (1) (2) Paolo Baessato (1) (2) Giorgio Fossa (1) (2) Pietro Guindani (1) (2) Ettore Morezzi (1) (2) Enzo Nicoli (2) Luigi Ragno (1) (4) Francesco Silva (2) Claudio Agostino Zulli (2) Board of Statutory Auditors Chairman Statutory Auditors Cesare Piovene Porto Godi Paolo Gualtieri Andrea Zaglio Independent Auditors Reconta Ernst & Young S.p.A. (1) Independent Director (2) Up to April 30, 2012 (3) Since April 30, 2012 (4) Up to July 4, 2012 (5) Since July 10, Sorin Group 2012 Annual Report

5 Executive Committee Provides support to the Chairman and the Board of Directors in connection with major decisions involving the Group. Its members are: Rosario Bifulco André-Michel Ballester Andrea Bovone Maurizia Squinzi (2) Massimo Tononi (1) Chairman Control and Risk Committee Provides consulting support and makes recommendations regarding internal control. Its members are: Giuseppe Carteni (2) Chairman Laura Iris Ferro (5) Maurizia Squinzi (2) Luigi Ragno (2) (4) Giuliano Asperti (1) Paolo Baessato (1) Claudio Agostino Zulli (1) Compensation Committee Provides consulting support with regard to the fees received by Directors, the compensation of top management and the Company s overall compensation policies. Its members are: Giovanni Pavese Giuseppe Carteni (2) Luciano Cattani (2) Paolo Baessato (1) Pietro Guindani (1) Chairman Related-party Transaction Committee Renders an opinion on the Company's procedure prior to its approval and reasoned opinions on individual related-party transactions. Its members are: Sergio Gianfranco Luigi Maria Dompé Giuseppe Carteni (2) Gino Santini (2) Luigi Ragno (3) (4) Giuliano Asperti (1) Paolo Baessato (1) Chairman (1) Up to April 30, 2012 (2) Since May 4, 2012 (3) Already a member of the Related-party Transaction Committee, w as appointed Committee Chairman on May 4, (4) Up to July 4, 2012 (5) Since July 10, Sorin Group 2012 Annual Report

6 SORIN GROUP Sorin Group is a multinational corporation, world leader in the field of medical devices to treat cardiovascular diseases. The Group develops, produces and distributes medical devices for cardiac surgery and the treatment of cardiac rhythm dysfunctions With about 3,700 employees worldwide, the Group is focused on three main therapeutic areas: Systems and disposable biomedical devices for extracorporeal circulation during heart surgery; Implantable prostheses to replace or repair native heart valves; Implantable devices, monitoring systems and accessories to treat cardiac rhythm dysfunctions. Each year, over one million patients in over 80 countries are treated with Sorin Group devices. Our lifesaving products are used in over 5,000 hospitals worldwide. Through steady growth and expansion, Sorin Group emerged as a market leader in medical technologies for cardiovascular diseases. The Group is the world leader in cardiopulmonary bypass, has a strong market position in the in the hearth valve segment and is a rapidly growing operator in the segment of devices to manage cardiac rhythm. Despite challenging market conditions, Sorin Group retained its global leadership position, particularly in the cardiovascular area. Driven by a commitment to improve patient care, Sorin Group is focused on supporting its longterm growth strategy through new investments in technology and geographic expansion projects. Sorin Group s products are lifesaving products; consequently, the Group is focused on meeting the strictest performance and quality standards and complying with the highest ethical standards. In 2012, Sorin Group s organization was based on three Business Units (Cardiopulmonary, Heart Valves and Cardiac Rhythm Management), corresponding to the three main therapeutic areas. Under a reorganization launched in the fourth quarter, the Cardiopulmonary and Heart Valves Business Units are being merged into a single Business Unit called Cardiac Surgery. Following this combination, starting in the first quarter of 2013, Sorin Group will publish results for the new Cardiac Surgery Business Unit on an aggregate basis. CARDIOPULMONARY (CP) Heart-lung machines Oxygenators Autotransfusion systems Other products Systems and disposable biomedical devices for extracorporeal circulation during heart surgery - Heart-lung machines - Cardiopulmonary systems (oxygenators, custom packs) - Autotransfusion systems and disposables - Perfusion tubing systems (PTS) - Cannulae - Endoscopic vessel harvesting systems in coronary surgery System for extracorporeal circulation include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories, and systems for autotransfusion and autologous blood washing. These systems are used to keep patients alive during open heart surgery by temporarily taking over cardiopulmonary functions. The Cardiopulmonary Business Unit offers a complete range of products for patients of every size: neonatal, pediatric and adult. 6 Sorin Group 2012 Annual Report

7 HEART VALVES (HV) Mechanical valves Tissue valves Self-anchoring tissue valve Annuloplasty rings Implantable prostheses to replace or repair native heart valves - Mechanical heart valves - Tissue heart valves - Self-anchoring tissue heart valves - Annuloplasty rings Sorin Group products include tissue and mechanical heart valves, as well annuloplasty rings to replace or repair dysfunctional heart valve or treat congenital diseases. CARDIAC RHYTHM MANAGEMENT (CRM) Bradyarrhythmia Tachyarrhythmia management systems management systems Heart-failure management systems Other products Implantable devices, monitoring systems and accessories to treat cardiac rhythm dysfunctions - Pacemakers - Implantable defibrillators - Systems to treat heart failure (CRT-D) - Programmers - Electrodes - Electrophysiology leads - Holter monitors Therapeutic devices in this area include: pacemakers to reestablish normal cardiac rhythm, implantable cardiac defibrillators, cardiac resynchronization therapy (CRT) systems to treat heart failure and monitor the risk of arrhythmia. Sorin Group has a global presence and its expertise, developed in over a decade of activity, is recognized throughout the global medical community. Listed on the Milan Stock Exchange since January 2004, Sorin Group is the result of the integration of successful brands, such as Sorin Biomedica, Dideco, Stöckert, Cobe Cardiovascular, Ela Medical and Carbomedics. 7 Sorin Group 2012 Annual Report

8 Sorin Group has a unique wealth of innovative technologies: SMARTVIEW TM monitoring system for patients wearing cardiac rhythm management devices Inspire family of new adult oxygenators for an optimized approach to perfusion FIRST CRT device with automated weekly optimization: SonR FIRST sutureless self-anchoring aortic valve: PERCEVAL TM S New XTRA autotransfusion system World s FIRST CRT-D with hemodynamic sensors: PARADYM FIRST semi rigid ring with unique 3D motion (Memo 3D ) FIRST oxygenator with integrated arterial filter SORIN* Synthesis World s FIRST sensor to optimize patient hemodynamics FIRST dual chamber adult oxygenator DIDECO* Avant World s FIRST dual-chamber ICD implant : ELA Medical* DEFENDER World s FIRST implant of a bi-ventricular pacing system (ELA Medical) FIRST neonatal oxygenator DIDECO Lilliput FIRST implant of a stented tissue heart valve (MITROFLOW* ) World s FIRST microcomputer within an ELA Medical s pacemaker FIRST modular heart-lung machine by STÖCKERT Sorin Group has a global presence, with activities in all regions of the world. Sales by Geography Manufacturing and R&D Locations 10% Rest of the world 10% Japan Europe 52% 731 million 28% North America CARDIOPULMONARY HEART VALVES CARDIAC RHYTHM MANAGEMENT Mirandola (Italy) Munich (Germany) Denver (United States) Vancouver (Canada) Saluggia (Italy) Clamart (France) 8 Sorin Group 2012 Annual Report

9 Sorin Group is driven by an unwavering commitment to health. 75 million euros devoted to R&D equal to more than 10% of sales revenues 15% of employees work in R&D in North America, France, Italy and Germany Ongoing collaborative relationships with specialists in cardiology, heart surgery and electrophysiology,as well as renowned universities and top research centers worldwide Relying on engineer-physician intelligence networks to develop innovative therapeutic solutions A portfolio of more than 2,000 patents Sorin Group s Vision Sorin Group wants to be recognized by the medical community, patients, shareholders, the financial community, the biomedical industry, government agencies and its employees not only as a top player in the heart valve and cardiopulmonary fields, but also as a world leader in the overall cardiovascular market and as a true innovator in the area of cardiac rhythm management. Sorin Group s organizational structure is based on three Business Units Cardiopulmonary, Cardiac Rhythm Management and Heart Valves supported by corporate functions and led by a management team with international experience in the medical industry. Following the reorganization launched at the end of 2012, the Cardiopulmonary and Heart Valve Business Units were merged into a single Business Unit called Cardiac Surgery. The Group s executive leadership team is presented below: Rosario BIFULCO Chairman André-Michel BALLESTER Chief Executive Officer Michel DARNAUD President, Cardiac Surgery & Intercontinental Stefano DI LULLO President, Cardiac Rhythm Management Edward ANDRLE Vice President Strategy & Business Development Stéphane BESSETTE Vice President Human Resources & Communication Demetrio MAURO Chief Financial Officer Brian SHERIDAN General Counsel Kieran TUITE Vice President Corporate Operations Jacques GUTEDEL Vice President Intercontinental 9 Sorin Group 2012 Annual Report

10 SUSTAINABILITY Because Sorin Group operates in the global biomedical industry, it is keenly aware of the responsibility that a company in its position must assume vis-à-vis all of its stakeholders. The highly innovative medical devices that Sorin Group produces are used every day by the medical profession to save human lives. The Group s mission is thus to develop, produce and distribute high quality cardiovascular medical devices, complying with the most stringent ethical standard and rules of conduct in its industry. This philosophy is also reflected in the Group s daily operating activities and in the relationships it entertains with customers, employees, shareholders, health care operators, partners, suppliers and professional associations within a commercial, health care, financial and/or regulatory framework. This section of the Report provides a brief overview of the Group s commitment to responsible management practices, not only economically, but also in social, environmental and governance terms. Ethical Responsibility and Governance Sorin Group operates in a particularly complex and strict compliance environment that reflects the specific regulatory framework of its industry globally and particularly in the United States. In this country, the Chief Compliance Officer (who reports directly to the Chief Executive Officer) is responsible, together with the Compliance Committee, for developing, promoting and maintaining all of the procedures needed to operate in the regulated U.S. med-tech market in accordance with the Corporate Integrity Agreement it signed in 2010 with the Office of Inspector General of the Department of Health and Human Services of the United States government. This agreement sets forth a compliance plan that defines all issues concerning training and interaction with health care operators. In the rest of the world, compliance activities are managed and coordinated by the Group s Legal and Internal Auditing functions. In Italy, the Group adopted in 2004 an Organization and Management Model in accordance with the requirements of Legislative Decree No. 231 of June 8, 2001, which introduced into the Italian legal system the principle of corporate administrative liability for certain types of crimes committed by Directors, executives or employees in the interest or for the benefit of a company. Consistent with this approach, Sorin Group adopted a Code of Conduct that sets forth the principles and guiding values that must be followed by anyone acting on the Company s behalf (members of governance bodies, managers, employees and associates) and by parties who engage in commercial and/or financial transactions with Sorin. In addition to reflecting specific governance and regulatory elements that are valid at the national level, the Code of Conduct constitutes a fundamental component of the Group s system of internal control that must be complied with and adopted at all Group locations worldwide. Special attention is devoted to transactions with suppliers. As a rule, all Group procurement transactions include a clause requiring compliance with Sorin s Code of Conduct. The processes applied to qualify and monitor suppliers are extremely detailed and the procedure used to verify supplier requirements includes controls concerning their ethical and social commitment. The Code of Conduct is available in the Corporate Governance section, Investor Relations page, of the corporate website: In addition, Sorin established toll-free telephone lines and a protected address devoted to ethical conduct that can be accessed to ask questions or raise issues. Sorin Group s Code of Conduct was updated in 2012 and the revised version was published in English, Italian, German and French. In 2013, it will be translated into Spanish, Japanese and, for the first time, into Arabic and Chinese. The new Code of Conduct has a completely redesigned layout and differs from the previous version in that it is clearer and more intuitive and contains a pamphlet for health care providers. The presentation of the new Code to the Chief Executive Officer in June 2012 was followed by training sessions provided to employees by the Corporate Counsel department both online and in the Group s main geographic regions. The rules of operation of Sorin s management and oversight bodies are defined in the Corporate Governance Model, which complies with the recommendations of Corporate Governance Code for Listed Companies promoted by Borsa Italiana S.p.A. and, more in general, is consistent with best international practices. Additional information about the Corporate Governance Model is available in the Report on Corporate Governance and the Company s Ownership Structure, which is available on Sorin Group s website, at the following address: 10 Sorin Group 2012 Annual Report

11 Lastly, consistent with sound corporate governance and the protection of stakeholders, a company is required to adopt an adequate risk management system. This area is under the jurisdiction of the Corporate Internal Auditing function, which performs each year a risk assessment (mapping of processes and activities; identification of financial and other risks with gap analysis; identification of existing measures; definition of an Audit Plan). The results of these activities and the Audit Plan are submitted for approval to the Internal Control and Risk Committee and the Board of Statutory Auditors. Environmental Responsibility The environmental impact is different in each of the three areas of activity in which the Group operates. However, in general terms, it is fair to say that, compared with other industries, the production of medical devices is an activity with a low environmental impact. Insofar as safety and the environment are concerned, the Group complies with the regulations in effect in the countries where it operates; in Italy, for example, the relevant statutes include Uniform Code No. 81/2008 (Uniform Safety Code) and Legislative Decree No. 152/2006 (environment). The Group s facility in Clamart (France), which produces devices distributed by the CRM Business Unit, received the ISO environmental certificate and the HQE (Haute qualité environnementale) certificate. While the other Group sites did not receive specific environmental certifications, it is important to keep in mind that all facilities are inspected and certified on a regular basis by such biomedical institutions as the FDA (Food and Drug Administration), G-MED (Groupement pour l'évaluation des dispositifs médicaux) and TUV (an independent certification entity). The Group adopted at its production facilities internal procedures to preserve the environment through a rational use of resources and energy sources, help protecting the ecosystem and, in general, continuously improve the Group s efficiency in the areas of health, safety and the environment. With regard to the environment, the Group adopted specific procedures concerning soil and water treatment, waste disposal and emissions into the atmosphere. The following project completed in 2012 or planned for 2013 in the environmental area are provided by way of example: Activities to bring Italian sites in compliance with SISTRI Regulations (the new control system for waste traceability). Design of a new sterilizing facility (100% insourced) with reduced emissions and consumption levels (ethylene oxide into the atmosphere, CO 2 almost eliminated (reduction of 100 tons), lower use of natural gas), resulting in less pollution (Mirandola site, Cardiopulmonary). This project, initially planned for 2012, was postponed to 2013, due to the earthquake (Mirandola site, Cardiopulmonary). Activities to recycle process-waste plastics for shipment to companies specialized in recycling it; a significant increase is expected for 2013 (10-15%) thanks to the promotion of differentiated waste collection at production facilities (Mirandola site, Cardiopulmonary). Launch of the JOIN SORIN S GREEN LEAF PROGRAM to make plant personnel more aware of the importance of differentiated waste collection inside cafeterias and a responsible use of electric power in offices and company facilities (Mirandola site, Cardiopulmonary). Activities for the distillation of significant process chemicals, such as Isopropyl alcohol and bromochloromethane by means of distillation systems to recover these substances from process waste. This system makes it possible to reuse 50% of these chemicals (Mirandola site, Cardiopulmonary). Upgrade of the active carbon emission reduction system installed at the solvent exhausts used in clean rooms, which further reduced the levels of volatile organic substances released from these facilities, bringing them well below the emissions limit allowed pursuant to law (Mirandola site, Cardiopulmonary). For 2013, as part of the renovation of the Central Office Building, plans to install automatic shutdown and zone segmentation equipment for the use of electric power and heating systems, which are expected to yield considerable savings of electric power (Mirandola site, Cardiopulmonary). Direct purchases of molded and pre-formed pump head components for heart-lung machines, instead of machining and milling solid bars, with a resulting reduction of about 30% in raw materials used (Munich site, Cardiopulmonary). Redesign of the waste collection and disposal service to increase the percentage of reusable materials (Munich site, Cardiopulmonary). 11 Sorin Group 2012 Annual Report

12 Installation of a steel central cooling system resulting in a 30% reduction in the use of cooling fluid (Munich site, Cardiopulmonary). Optimization of the plant s compressed air system with installation of automatic control. Expected energy savings of 20% (Munich site, Cardiopulmonary). Utilization of a new Streamline Recycle Compactor to recycle cardboard, paper, plastics, glass, metal, etc. (all recyclable materials) at a single compactor, which reduced by 50% the volume of waste sent to landfills (Arvada site, Cardiopulmonary). Optimization of the lighting system, with resulting energy savings, by switching from fluorescent to the more energy efficient T8 lighting system (Arvada site, Cardiopulmonary). Significant reduction of non-conformity issues regarding practices for the handling and storage of chemicals (Clamart site, Cardiac Rhythm Management). Training of 20% of the sales force to make them more responsive to the need for a reduction of driving risks and a more environmentally responsible style of driving. Reduction of 10% in consumption of water and electric power (Clamart site, Cardiac Rhythm Management). Removal of asbestos cement roofing still present at Company owned buildings and mapping of all pipes of heating and cooling systems to check for the presence of asbestos (Saluggia site, Heart Valves). Differentiated waste collection (paper, plastic, glass) at all Group locations. Human Resources With about 3,700 employees worldwide, Sorin is constantly mindful of the needs of its human resources. The Group is committed to providing a healthy, safe and discrimination free work environment. Occupational safety prevention and protection is handled at the level of the individual Group companies, in accordance with the regulations in effect locally and with the aim of preventing accidents and protecting the physical integrity of employees. At all of it main production facilities, the Group established Safety Committees responsible for continuously monitoring and improving the work environment. In 2012, as was the case in previous years, there were no fatal or very serious accidents and the rate of lost workdays due to accidents continued to follow a downward trend. Special attention is paid to defining effective systems to develop relevant professional competencies and training investments are being made to foster the growth both of the Company and its employees. Sorin Group established a Sorin University, with international training courses available in various languages. A total of 15 training modules have been implemented thus far. Training programs launched in 2012 included the following: Talent management projects for the Research and Development function concerning Time to Market and New Product Launches. Training courses to help the sales force develop medical-scientific competencies. Short-term training paths for executives and middle managers. Another important development of 2012 was Sorin Group s decisions to open ACCESS Advanced Center for Continuous Education on Scientific Solutions, its own training center located near Paris. This innovative training center makes it possible to provide quality training with classroom lessons, meetings of professionals and carefully targeted workshops. ACCESS offers a complete series of training modules designed for electrophysiologists, cardiologists and other health-care professionals. In the area of internal communications, the following initiatives were carried out to make Group employees aware of the objectives achieved and share future short and long-term strategic objectives: Quarterly CEO conference calls with key Group managers; All-employee meetings held at least three times a year at the Group s main production facilities, open to all employees with a top-down, interactive approach based on specific Q&A sessions. Department Team meetings, held monthly with the aim of obtaining feedback from the team to establish bottom-up communications as a means of assessing the progress made on specific projects. New hires 90 breakfast sessions (each quarter or twice a year, depending on the number of new hires), during which Business Unit and department managers meet new hires. Intranet, a system to share information (procedures, policies, models, announcements). 12 Sorin Group 2012 Annual Report

13 In the areas of industrial relations and the involvement of labor unions, the Group signed collective bargaining agreements in accordance with local laws. Lastly, Sorin adopts employee development, compensation and incentivization systems that acknowledge and reward merit and performance. The compensation and incentivization policy includes the following: Collective profit sharing bonuses tied to productivity and profitability at all of the Group s main production sites. Incentive systems for the sales force and office staff, based on individual performance and the financial performance of their respective areas or Business Units. Variable annual compensation systems for middle and top management, tied to the achievement of personal and Group business targets. Long-term incentive plan (LTI) through the award of stock grants to top management and to manager with key roles within the Group, tied to business performance targets. Additional information about this three-year rolling program is provided in Note 30 to the Consolidated Financial Statements and in the Report on Corporate Governance and the Company s Ownership Structure, which is available on Sorin Group s website, at the following address: All Sorin employees are required to comply with and adopt the Group s Code of Conduct; compliance with this requirement is a primary objective in the assessment of personal performance. Personnel policies are defined by the Human Resource function of the Group s Parent Company and are implemented by the Human Resource managers of the individual Business Units and the main geographic regions. Social Responsibility Consistent with its activity as a manufacturer of medical devices for cardiovascular diseases, Sorin Group carried out a series of activities related to its core business, such as development of clinical trials and attendance at medicalscientific congresses and conventions, which, for the most part, are aimed at improving quality of life for patients suffering from cardiovascular diseases and promote their wellbeing. Among the social initiatives carried out by Sorin Group, one particularly worthy of mention is the partnership established with the nonprofit association Bambini Cardiopatici nel Mondo to support the association s humanitarian missions in the developing countries for children suffering from congenital cardiac diseases. Up to this point, the association performed over 2,100 life-saving cardiac surgery procedures during more than 300 surgical missions in 20 countries worldwide. The association, in addition to helping and treating directly children suffering from heart diseases, is involved in establishing the conditions for a sustainable development of health care in the countries where it operates: it builds health care facilities, donates technical and surgical equipment and field trains local physicians directly. In 2012, Sorin Group donated to the association 250,000 euros, with another 5,000 euros contributed by Group employees. In addition, Sorin Group donated life-saving devices and incentivized the involvement of its employees as volunteers in activities promoted by the association. Another noteworthy social initiative was the establishment of the Earthquake Relief Fund to benefit Sorin employees affected by the earthquakes of May 20 and 29, 2012 in the Emilia-Romagna region and Mirandola specifically. Subsequent to these dramatic events, the Company launched a fund raising drive in which all Sorin employees could donate a portion of their salary to benefit the victims of the earthquake, with the Company agreeing to match the amount raised by employees. The amount raised totaled 240,000 euros, which was used to help 60 employees severely affected by the earthquake. 13 Sorin Group 2012 Annual Report

14 INVESTOR RELATIONS Sorin maintains an ongoing dialog with the financial community with the objective of delivering a steady flow of information to its shareholders, institutional investors, financial analysts and the financial markets in general, while complying fully with the principles of transparency and equal treatment for everyone. Sorin uses all of the usual financial communication tools and dialogs with financial operators by means of one-on-one meetings and Group presentations, roadshows, meetings with financial analysts, company visits by institutional investors and analysts, conference calls, attendance at industry conference and press releases, and through a constantly updated Investor Relations page of the corporate website and economic-financial publications. The main events providing interaction with the financial community held in 2012 are reviewed below: On September 24, 20012, the Investor and Analyst Day presentation to the financial community at Palazzo Mezzanotte, in Milan, accessible also in videoconferencing mode, during which the Group s top management team reviewed the guidelines of the strategic plan and provided a detailed update of the Group s business. This event was attended by the following guests: Angelo Auricchio (Director Clinical Electrophysiology Program, Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, and Professor of Cardiology, Magdeburg University, Germany) and Mattia Glauber (Director of the Thoracic Cardiac Surgery Unit, Fondazione Toscana G. Monasterio, Ospedale Del Cuore G. Pasquinucci, Massa, Italy). Attendance at numerous international biomedical or health care sector conferences organized by major international financial institutions (including Citi, Piper Jaffray, Goldman Sachs, Jefferies and Berenberg Bank, mostly in New York and London). Attendance at conference for Italian listed companies, namely the Italian Investment Conference, organized by Unicredit in collaboration with Kepler Capital Markets and the Small & Mid Cap Event organized by Equita, both held in Milan. Participation in the Italian Equity Roadshow organized by Borsa Italiana and Banca IMI for the New York financial market. Conference calls held to announce annual and interim data. As for the coverage by financial analysts, four new firms began to cover the Sorin stock in 2012: Kepler, a major European broker, in February; Berenberg Bank, a top German financial institution, in May; Fidentiis, a Spanish independent research firm and broker, in September; and Bryan Garnier, a major French broker, also in September. The 10 securities dealers who currently follow the stock published several reports about the Group, all providing a generally positive recommendation. Lastly, in order to ensure that the expectations of the financial markets match as closely as possible its actual results, the Company continued to provide guidance about its projected operating and financial results, both on an annual and quarterly basis. Contact information for the Investor Relations Department, which is the entity responsible for financial communications is provided below: Investor Relations Tel.: Fax: Sorin s stock price, which was euros at December 30, 2011, improved to euros at December 28, 2012, for an average price for the year of 1.55 euros. The stock price increased by about 42% in 2012, while the Italian market as a whole (FTSE MIB Index) appreciated by 8%. In 2012, the stock s average daily trading volume was generally over 1 million shares with a Free Float Velocity, computed as the ratio of the annual trading volume to the share float, of 93%. 14 Sorin Group 2012 Annual Report

15 The chart below tracks the performance of the Sorin stock (SRN) compared with the FTSE All Shares Italia index for the 12 months ended December 28, SRN FTSE At December 31, 2012, the Company s share capital was comprised of 478,738,144 shares, par value 1 euro each. The Shareholders Meeting or April 30, 2012 and, subsequently, the Board of Directors, at a meeting held on May 4, 2012, launched a new share buyback program. The purpose of this program is to buy, in one or more installments, up to 10 million common shares, in order to acquire treasury shares earmarked to implement existing and future stock incentive plans reserved for Directors and/or employees and/or associates of the Company and its subsidiaries and, consequently, exclusively to implement the new Long-term Incentive Stock Plan and for the deferment and conversion into shares of the 2012 Short-term Incentive. The share buyback authorization is valid for 18 months counting from the date of the resolution of the Shareholders Meeting, i.e., until October 31, On June 1, 2012, 1,281,787 treasury shares were used for grants awarded under the Long-term Incentive Stock Plan. A total of 975,000 azioni treasury shares were acquired in At December 31, 2012, Sorin S.p.A. held 2,626,813 treasury shares, equal to % of its share capital. 15 Sorin Group 2012 Annual Report

16 Major shareholders (with equity stakes equal to more than 2% of the share capital) at December 31, 2012, determined based on the information received by the Company, are listed below: Name of filer Name Direct shareholder % interest in voting capital BIOS S.p.A BIOS S.p.A EQUINOX TWO S.c.a. TOWER 6 BIS S.a.r.l GENERAL ELECTRIC COMPANY GE CAPITAL EQUITY HOLDINGS BANCA MONTE DEI PASCHI DI SIENA S.p.A. BANCA MONTE DEI PASCHI DI SIENA S.p.A FINSOE S.p.A. UNIPOL ASSICURAZIONI S.p.A ZADIG GESTION (LUXEMBOURG) S.A. ZADIG GESTION (LUXEMBOURG) S.A A Shareholders Agreement signed by Mittel S.p.A., Equinox Two S.c.A., Banca Monte dei Paschi di Siena S.p.A. and Unipol Gruppo Finanziario S.p.A., each for the respective equity stake held directly or indirectly in Sorin S.p.A., as amended, has been in effect since November 18, On August 3, 2012, the parties entered into an agreement extending to November 18, 2013 the duration of the Shareholders Agreement, which would have expired on November 18, By the agreement executed on August 3, 2012, the abovementioned parties mutually expressly waived the cancellation right provided under the old agreement (exercisable until August 18, 2012) and changed the duration of the agreement, stipulating that it would be in effect until November 18, 2013, with exclusion of the automatic renewal clause after the abovementioned expiration date. 16 Sorin Group 2012 Annual Report

17 CONSOLIDATED FINANCIAL HIGHLIGHT 12/31/12 12/31/11 Income Statement Data Net revenues (1) 731,1 743,4 EBITDA before special items 101,8 128,3 EBIT 36,9 87,2 EBIT before special items 58,0 87,4 Profit (Loss) before taxes 22,6 79,6 Net profit 23,0 57,8 Adjusted net profit 41,9 58,0 Statement of Financial Position Data Net invested capital 647,6 628,1 Net indebtedness (2) (87,8) (105,9) Shareholders equity 559,8 522,2 Other Data Number of employees at end of the year Average number of employees for the year Data per Share (in euros) Profit (loss) per share: - basic and diluted, based on the net profit (loss) for the year 0,048 0,122 - basic and diluted, based on the net profit (loss) from continuing operations 0,048 0,122 Dividend per share Shareholders equity per share 1,169 1,101 Stock market price (average for the period) 1,557 1,749 Key Indicators EBITDA before special items/net revenues (% ) 13,9 17,3 EBIT/Net revenues (% ) 5,0 11,7 EBIT before special items/net revenues (% ) 7,9 11,8 EBIT/Average net invested capital (% ) 5,8 14,4 Net profit/net revenues (% ) 3,1 7,8 Adjusted net profit/net revenues (% ) 5,7 7,8 Net profit (loss)/average shareholders equity (% ) 4,2 11,8 Net indebtedness/shareholder s equity 0,16 0,20 (IN MILLIONS OF EUROS) (1) Includes sales and serv ice rev enues and cost recov eries. (2) A breakdow n of net indebtedness is prov ided after the consolidated statement of financial position. 17 Sorin Group 2012 Annual Report

18 Foreword The financial statements at December 31, 2012 were prepared in accordance with the international financial reporting standards (IFRS) published by the International Accounting Standards Board (IASB) and approved by the European Union and comply with the provisions enacted to implement Article 9 of Legislative Decree No. 38/2005. The abbreviation IFRS also stands for the International Accounting Standards (IAS) currently still in effect and all of the interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC), including earlier interpretations issued by the Standing Interpretations Committee (SIC). The international accounting principles adopted are the same as those applied to prepare the consolidated financial statements at December 31, 2011, except as noted in Note 1 to the Consolidated Financial Statements. In May 2012, a powerful earthquake struck the area around Mirandola (MO) where one of the Group s production facilities is located. No Group employees were physically injured by the earthquake, but the Mirandola plant was damaged and production activities were temporarily interrupted. The Mirandola plant is one of the seven production facilities operated by the Group. Production of oxygenators and autotransfusion kits, which are part of the Cardiopulmonary Business Unit, is concentrated at this plant. Other activities related to the oxygenator and autotransfusion product lines and the entire heart-lung machine segment are carried out at plants located in Denver (Colorado, United States) and Munich (Germany). As a result, these products did not suffer any negative repercussions, and the same was true for all of the devices included in the product lines of the Cardiac Rhythm Management Business Unit and the Heart Valves Business Units, which were not affected in any way by seismic events. Thanks to the extraordinary commitment of the staff at the Mirandola site, despite the extensive damage caused by the earthquake, production resumed earlier than the date originally anticipated and communicated to the market, reaching levels higher than those reported before the earthquake. The financial statements at December 31, 2012 were prepared on a going concern basis. Specifically, the Group concluded that, even though the economic and financial environment remains challenging and despite the abovementioned seismic event, there were no material uncertainties (as defined in Paragraph 25 of IAS 1) as to the Company's ability to continue as a going concern, owing in part to the actions already taken to address perceived risks and adapt the Group s operating and financial structure to the new economic environment. California Medical Laboratories Inc. ( CalMed ), a U.S. company that produces high quality cardiovascular cannulae, was acquired in July CalMed develops, produces and distributes a complete portfolio of cannulae, catheters and accessories for heart surgery. Also in July the Group acquired in the United States a minority interest in Cardiosolutions Inc., a startup company involved in the development of an innovative percutaneous technology for patients suffering from mild and acute mitral valve regurgitation. Under the terms of the agreement, Sorin has an option to acquire the company s entire share capital in the future. Another acquisition, completed in the United States in September, involved a minority interest, with an option to buy the entire share capital, in Caisson Interventional LLC, a company engaged in the development of innovative percutaneous anchoring technologies for valve prostheses. In November, the Group acquired in Belgium the entire share capital of Neurotech SA, a company that develops neurostimulation devices. In the same month, a minority interest, with an option to buy the entire share capital, was acquired in HighLife SAS, a French company engaged in the development of an innovative technology for transcatheter mitral valve replacement for patients suffering from regurgitation. In the fourth quarter of 2012, the Group launched a reorganization that involves merging the Cardiopulmonary and Heart Valves Business Units into a single Business Unit called Cardiac Surgery. Following this combination, starting in the first quarter of 2013, Sorin Group will publish the data of the new Cardiac Surgery Business Unit on an aggregate basis. 18 Sorin Group 2012 Annual Report

19 Starting with the 2012 financial statements, the Group opted for early adoption of the amendments to IAS 19 Employee Benefits, recognizing the net revaluation of liabilities (assets) for defined benefits in other components of comprehensive income and no longer in profit or loss. As required by IAS 18, this change was applied retroactively and, consequently, the following adjustments were made to the 2011 financial statements: - Increase of 477,000 euros in Personnel expense; - Decrease of 284,000 euros in Income taxes; - Decrease of 193,000 euros in Result for the year. In this document, amounts are in millions of euros, with one decimal, in the Report on Operations, and in thousands of euros in the consolidated financial statements and the separate financial statements of Sorin S.p.A. As a result, some rounding of figures difference may occur in some schedules. Sorin S.p.A. further announces that, pursuant to Article 70, Section 8, and Article 71, Section 1-bis, of Consob Regulation No /99, as amended by Resolution No of January 20, 2012, it is availing itself of the option of non-complying with the obligation to publish the information memoranda required in connection with material transactions involving mergers, demergers, capital increases through conveyances of assets in kind, acquisitions and divestments. 19 Sorin Group 2012 Annual Report

20 REPORT ON OPERATIONS AT DECEMBER 31, Sorin S.p.A Consolidated Financial Statements Report on Operations at December 31, 2012

SORIN GROUP ANNOUNCES FINAL FINANCIAL RESULTS FOR 2014

SORIN GROUP ANNOUNCES FINAL FINANCIAL RESULTS FOR 2014 Press Release SORIN GROUP ANNOUNCES FINAL FINANCIAL RESULTS FOR 2014 Consolidated results for 2014: Revenues were 746.9 million, up 3.4% 1 compared to 2013; Adjusted net profit 2 was 55.1 million compared

More information

REPORT ON OPERATIONS CONSOLIDATED FINANCIAL STATEMENTS STATUTORY FINANCIAL STATEMENTS OF SORIN SPA AT DECEMBER 31, 2009

REPORT ON OPERATIONS CONSOLIDATED FINANCIAL STATEMENTS STATUTORY FINANCIAL STATEMENTS OF SORIN SPA AT DECEMBER 31, 2009 REPORT ON OPERATIONS CONSOLIDATED FINANCIAL STATEMENTS STATUTORY FINANCIAL STATEMENTS OF SORIN SPA AT DECEMBER 31, 2009 SORIN S.p.A. Registered and Administrative Offices: Tel.:+39 02 69969711 Share Capital:

More information

First Quarter 2014 Conference Call

First Quarter 2014 Conference Call First Quarter 2014 Conference Call 29 April, 2014 SORIN GROUP Presentation 1 DISCLAIMER This presentation contains management preliminary estimates and forward-looking statements, including information

More information

Board of Directors, Board of Statutory Auditors, Independent Auditors, Committees 2. Sorin Group 4. Consolidated Financial Highlights 6

Board of Directors, Board of Statutory Auditors, Independent Auditors, Committees 2. Sorin Group 4. Consolidated Financial Highlights 6 ANNUAL REPORT 2008 CONTENTS Board of Directors, Board of Statutory Auditors, Independent Auditors, Committees 2 Sorin Group 4 Consolidated Financial Highlights 6 Report on Operations 7 Alternative Performance

More information

INSIDE INFORMATION ESTABLISHMENT OF JOINT VENTURE

INSIDE INFORMATION ESTABLISHMENT OF JOINT VENTURE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness,

More information

Consolidated sales of 6,347 million euros, up 10% on a like-for-like basis (7% as reported)

Consolidated sales of 6,347 million euros, up 10% on a like-for-like basis (7% as reported) 14.18 Order intake surged 25% to 9.1 billion euros Sales came in at 6.3 billion euros, up 10% like for like (7% as reported) Operating margin (1) up 15% to 442 million euros, or 7.0% of sales Net income

More information

INTERIM REPORT ON OPERATIONS AS OF SEPTEMBER 30, 2015 BOARD OF DIRECTORS REPORT ON MANAGEMENT PERFORMANCE OF THE ENGINEERING GROUP

INTERIM REPORT ON OPERATIONS AS OF SEPTEMBER 30, 2015 BOARD OF DIRECTORS REPORT ON MANAGEMENT PERFORMANCE OF THE ENGINEERING GROUP ENGINEERING INGEGNERIA INFORMATICA S.p.A. HEADQUARTERS IN ROME, VIA SAN MARTINO DELLA BATTAGLIA, 56 UNDERSIGNED AND FULLY PAID UP SHARE CAPITAL 31,875,000 TRADE REGISTER NO. 00967720285 ROME CHAMBERS OF

More information

Billions of euro 2013 2015 2017 EBITDA ~16.0 ~ 16.0 17-18 Net Ordinary Income ~ 3.0 ~ 3.3 4-5

Billions of euro 2013 2015 2017 EBITDA ~16.0 ~ 16.0 17-18 Net Ordinary Income ~ 3.0 ~ 3.3 4-5 Disclosures supplementing the Annual Report for the year ended December 31, 2012 requested by CONSOB pursuant to the provisions of Article 114, paragraph 5, of Legislative Decree 58 of February 24, 1998

More information

Cembre (a STAR listed company): approved a distribution of a 0.26 dividend per share

Cembre (a STAR listed company): approved a distribution of a 0.26 dividend per share Joint-stock Company Main Office: Via Serenissima, 9 25135 Brescia VAT no: 00541390175 Share Capital: 8,840,000 fully paid up Registration no: 00541390175 tel.: +39 0303692.1 fax: +39 0303365766 Press release

More information

OPTION REPORTS FULL YEAR 2013 RESULTS

OPTION REPORTS FULL YEAR 2013 RESULTS OPTION REPORTS FULL YEAR 2013 RESULTS Leuven, Belgium March 13, 2014 Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), a global leader in wireless connectivity, security and experience, today announced

More information

FOURTH QUARTER 2005. Highlights from fourth quarter 2005 include:

FOURTH QUARTER 2005. Highlights from fourth quarter 2005 include: FOURTH QUARTER 2005 Highlights from fourth quarter 2005 include: Revenues of 675 MNOK (+2% percent relative to fourth quarter 2004, +6% after adjusting for currency effects and acquisitions/disposals)

More information

PRESS RELEASE. Board of Directors approves results as of December 31 2014

PRESS RELEASE. Board of Directors approves results as of December 31 2014 PRESS RELEASE Board of Directors approves results as of December 31 2014 SOGEFI (CIR GROUP): REVENUES AT OVER 1.3 BLN (+1.1%; +4.7% AT SAME EXCHANGE RATES), NET INCOME AT 3.6 MLN MARGINS LOWER BECAUSE

More information

LOTTOMATICA GROUP ANNOUNCES RESULTS FOR THE THIRD-QUARTER AND NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2011

LOTTOMATICA GROUP ANNOUNCES RESULTS FOR THE THIRD-QUARTER AND NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2011 PRESS RELEASE LOTTOMATICA GROUP ANNOUNCES RESULTS FOR THE THIRD-QUARTER AND NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2011 Consolidated Financial and Business Highlights Continued quarterly Revenue growth

More information

Financial Information

Financial Information Financial Information Solid results with in all key financial metrics of 23.6 bn, up 0.4% like-for like Adjusted EBITA margin up 0.3 pt on organic basis Net profit up +4% to 1.9 bn Record Free Cash Flow

More information

Investor Presentation CRM business. January 2014

Investor Presentation CRM business. January 2014 Investor Presentation CRM business January 2014 Agenda CRM Industry Overview Sorin s Business Overview Joint Venture Overview Joint Venture Rationales 2 CRM Industry Overview Market Status: Global CRM

More information

HALF YEAR REPORT AS OF JUNE 30

HALF YEAR REPORT AS OF JUNE 30 2 0 1 4 HALF YEAR REPORT AS OF JUNE 30 T O O U R S H A R E H O L D E R S Dear shareholders, ladies and gentlemen, The Nemetschek Group continued its successful development in the second quarter of 2014

More information

Sales and profit expectations for 2014 fulfilled Distribution proposed Share buy-back agreed

Sales and profit expectations for 2014 fulfilled Distribution proposed Share buy-back agreed Press release Sales and profit expectations for 2014 fulfilled Distribution proposed Share buy-back agreed Sales up 4 percent on previous year Gross and EBIT margins reduced by temporary start-up costs

More information

Net sales increased with 16% to SEK 76.1 m (65.6). Net sales for the last four quarters totalled SEK 255.0 m (306.6)

Net sales increased with 16% to SEK 76.1 m (65.6). Net sales for the last four quarters totalled SEK 255.0 m (306.6) HMS Networks AB (publ) Interim report January-March 2010 First quarter 2010 Net sales increased with 16% to SEK 76.1 m (65.6). Net sales for the last four quarters totalled SEK 255.0 m (306.6) Operating

More information

Year Ended December 31, 2011

Year Ended December 31, 2011 Cigna Reports Full Results Projects Strong Business Growth for 2012 BLOOMFIELD, Conn., February 02, 2012 - Cigna Corporation (NYSE: CI) today reported fourth quarter and full year results that included

More information

Reed Elsevier Results 2013 Erik Engstrom, CEO Duncan Palmer, CFO

Reed Elsevier Results 2013 Erik Engstrom, CEO Duncan Palmer, CFO Reed Elsevier Results Erik Engstrom, CEO Duncan Palmer, CFO FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the US Securities Act of

More information

2015 Results and Prospects

2015 Results and Prospects PRESS RELEASE Paris, 23 March 2016 2015 Results and Prospects Revenues: 2,579.3 million, up 3.2% EBITDA: 342.0 million, an operating margin of 13.3% 2016 Objectives: revenues close to 3 billion and an

More information

Hydrogenics Reports Fourth Quarter and Full Year 2015 Results

Hydrogenics Reports Fourth Quarter and Full Year 2015 Results PRESS RELEASE Hydrogenics Reports Fourth Quarter and Full Year 2015 Results Kolon, Alstom, and China Wins Highlight 2015 Achievements Mississauga, Ontario. March 9, 2016 Hydrogenics Corporation (NASDAQ:

More information

Advanced Vision Technology Ltd. 3 Months Report 2015 January 1st - March 31st

Advanced Vision Technology Ltd. 3 Months Report 2015 January 1st - March 31st Advanced Vision Technology Ltd. 3 Months Report 2015 January 1st - March 31st Dear Shareholder, In the first quarter of 2015, total order bookings were $12.9 million, compared with $13.1 million in the

More information

Disclosure document on the Long-Term Incentive Plan for the management of the Finmeccanica Group

Disclosure document on the Long-Term Incentive Plan for the management of the Finmeccanica Group Disclosure document on the Long-Term Incentive Plan for the management of the Finmeccanica Group Pursuant to Article 84-bis of Consob s Issuers Regulation approved with resolution no. 11971 of 14 May 1999,

More information

First quarter 2015 results 1

First quarter 2015 results 1 First quarter results 1 Luxembourg, May 5, Highlights Health and Safety frequency rate 2 of 1.3x in Q1 compared to 1.8x in Q4. Shipments of 469 thousand tonnes in Q1 compared to shipments of 439 thousand

More information

Full year and fourth quarter 2014 results 1

Full year and fourth quarter 2014 results 1 Full year and fourth quarter results 1 Luxembourg, February 12, 2015 Highlights Health and Safety frequency rate 2 of 1.1x in compared to 1.3x in 2013. Shipments of 1,813 thousand tonnes in full year,

More information

Consolidated Settlement of Accounts for the First 3 Quarters Ended December 31, 2011 [Japanese Standards]

Consolidated Settlement of Accounts for the First 3 Quarters Ended December 31, 2011 [Japanese Standards] The figures for these Financial Statements are prepared in accordance with the accounting principles based on Japanese law. Accordingly, they do not necessarily match the figures in the Annual Report issued

More information

Half Year 2015 Results

Half Year 2015 Results Half Year 2015 Results Letter to shareholders LifeWatch First Half Highlights Revenue growth of 9.1% to USD 52.5 million Above-market growth of over 12% in core monitoring services resulting in market

More information

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014 Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

PRESS RELEASE 2013 RESULTS APPROVED ITALIA INDEPENDENT GROUP CONTINUES TO GROW

PRESS RELEASE 2013 RESULTS APPROVED ITALIA INDEPENDENT GROUP CONTINUES TO GROW PRESS RELEASE 2013 RESULTS APPROVED ITALIA INDEPENDENT GROUP CONTINUES TO GROW - Net revenue + 59.1%, equal to 24.9 million euro (15.7 million euro for the year ended 31 December 2012) - Gross margin +

More information

Methorios Capital. Small Cap Conference. Milan, 29th November 2012 Borsa Italiana Palazzo Mezzanotte 11.30 Room Gialla

Methorios Capital. Small Cap Conference. Milan, 29th November 2012 Borsa Italiana Palazzo Mezzanotte 11.30 Room Gialla Methorios Capital Small Cap Conference Milan, 29th November 2012 Borsa Italiana Palazzo Mezzanotte 11.30 Room Gialla 2 Methorios Capital Group Business overview Key Numbers & Strategies 3 3 Overview Methorios

More information

Management s Discussion and Analysis

Management s Discussion and Analysis Management s Discussion and Analysis of Financial Conditions and Results of Operations For the quarter and six months ended June 30, 2012 All figures in US dollars This Interim Management s Discussion

More information

FOR IMMEDIATE RELEASE

FOR IMMEDIATE RELEASE FOR IMMEDIATE RELEASE O-I REPORTS FULL YEAR AND FOURTH QUARTER 2014 RESULTS O-I generates second highest free cash flow in the Company s history PERRYSBURG, Ohio (February 2, 2015) Owens-Illinois, Inc.

More information

Summary of Financial Statements (J-GAAP) (Consolidated)

Summary of Financial Statements (J-GAAP) (Consolidated) Summary of Financial Statements (J-GAAP) (Consolidated) February 10, 2016 Company Name: Sodick Co., Ltd. Stock Exchange: Tokyo Stock Exchange, 1st Section Code Number: 6143 URL: http://www.sodick.co.jp

More information

Earnings Release Q2 FY 2015 January 1 to March 31, 2015

Earnings Release Q2 FY 2015 January 1 to March 31, 2015 Munich, Germany, May 7, 2015 Earnings Release FY 2015 January 1 to March 31, 2015 Portfolio gains drive income»for business volume, we performed well in our markets. The profitability of our Industrial

More information

BOARD OF DIRECTORS REPORT ON MANAGEMENT PERFORMANCE OF THE ENGINEERING GROUP

BOARD OF DIRECTORS REPORT ON MANAGEMENT PERFORMANCE OF THE ENGINEERING GROUP ENGINEERING INGEGNERIA INFORMATICA SpA ROME, Via San Martino della Battaglia, 56 THE UNDERSIGNED AND FULLY PAID UP SHARE CAPITAL IS EQUAL TO 31,875,000 TRADE REGISTER NO. 00967720285 ROME CHAMBERS OF COMMERCE

More information

Tower International Reports Solid Third Quarter And Raises Full Year Outlook

Tower International Reports Solid Third Quarter And Raises Full Year Outlook FOR IMMEDIATE RELEASE Tower International Reports Solid Third Quarter And Raises Full Year Outlook LIVONIA, Mich., November 3, 2011 Tower International, Inc. [NYSE: TOWR], a leading integrated global manufacturer

More information

Second Quarter Results of Operations

Second Quarter Results of Operations PRESS RELEASE Besi Posts Strong Q2 and H1-15 Results. Significant Expansion of Net Cash Position vs. 14 Duiven, the Netherlands, July 23, - BE Semiconductor Industries N.V. (the Company" or "Besi") (Euronext

More information

Cytec Announces First Quarter 2010 Results. As-Adjusted EPS of $0.66, Significantly Above Prior Year As-Adjusted EPS of $0.06

Cytec Announces First Quarter 2010 Results. As-Adjusted EPS of $0.66, Significantly Above Prior Year As-Adjusted EPS of $0.06 cytec News & Information Cytec Industries Inc. Five Garret Mountain Plaza Woodland Park, New Jersey 07424 www.cytec.com Contact: Jodi Allen (Investor Relations) (973) 357-3283 Release Date: Immediate Cytec

More information

Intel Reports Fourth-Quarter and Annual Results

Intel Reports Fourth-Quarter and Annual Results Intel Corporation 2200 Mission College Blvd. P.O. Box 58119 Santa Clara, CA 95052-8119 CONTACTS: Reuben Gallegos Amy Kircos Investor Relations Media Relations 408-765-5374 480-552-8803 reuben.m.gallegos@intel.com

More information

SECOND QUARTER 2006. Highlights from second quarter 2006 include: Strong performance in all business areas

SECOND QUARTER 2006. Highlights from second quarter 2006 include: Strong performance in all business areas SECOND QUARTER 2006 Highlights from second quarter 2006 include: Strong performance in all business areas Revenues of 1,021 MNOK (+72 percent relative to 593 MNOK in second quarter 2005) Operating profit

More information

FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3.

FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3. FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3.00 Fiscal Year 2014 Net Sales Increase 8% to $3.510 Billion;

More information

Travel24.com AG. Quarterly Report Q1 2015

Travel24.com AG. Quarterly Report Q1 2015 Travel24.com AG Quarterly Report Q1 2015 2 Selected Key Group Data January 1 - March 31 Change In thousands of euro 2015 2014 % Revenue 4,494 7,810-42 % EBIT 806 1,231-35 % Net profit 66 518-87 % Earnings

More information

Consolidated Financial Results for the First Two Quarters of the Fiscal Year Ending March 31, 2016 (Japan GAAP)

Consolidated Financial Results for the First Two Quarters of the Fiscal Year Ending March 31, 2016 (Japan GAAP) Consolidated Financial Results for the First Two Quarters of the Fiscal Year Ending March 31, 2016 (Japan GAAP) Name of Listed Company: Yokogawa Electric Corporation (the Company herein) Stock Exchanges

More information

Herzogenaurach, Germany, July 27, 2004 PUMA AG announces its consolidated nd

Herzogenaurach, Germany, July 27, 2004 PUMA AG announces its consolidated nd P Quarter P Half-Year For immediate release MEDIA CONTACT: INVESTOR CONTACT: U.S.A.: Lisa Beachy, Tel. +1 617 488 2945 Europe: Ulf Santjer, Tel. +49 9132 81 2489 Dieter Bock, Tel. +49 9132 81 2261 Herzogenaurach,

More information

Consolidated financial statements

Consolidated financial statements Summary of significant accounting policies Basis of preparation DSM s consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted

More information

Annual General Meeting of Fresenius SE on May 12, 2010. Speech of Dr. Ulf M. Schneider, Chairman of the Management Board

Annual General Meeting of Fresenius SE on May 12, 2010. Speech of Dr. Ulf M. Schneider, Chairman of the Management Board Annual General Meeting of Fresenius SE on May 12, 2010 Speech of Dr. Ulf M. Schneider, Chairman of the Management Board The spoken word has precedence. Chart: Welcome Good morning, ladies and gentlemen.

More information

Press release Regulated information

Press release Regulated information Press release Regulated information 26 February 2010 Annual results 2009 Press Katelijn Bohez T +32 56 23 05 71 Investor Relations Jacques Anckaert T +32 56 23 05 72 www.bekaert.com www.bekaert.mobi Bekaert

More information

D.E MASTER BLENDERS 1753 N.V.

D.E MASTER BLENDERS 1753 N.V. UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months periods ended 31 December 2012 and 31 December 2011 TABLE OF CONTENTS UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL

More information

First quarter ended March 31, 2013 Sales at $422 million and adjusted earnings at $7 million

First quarter ended March 31, 2013 Sales at $422 million and adjusted earnings at $7 million 170 INDUSTRIEL BLVD. BOUCHERVILLE (QUÉBEC) CANADA, J4B 2X3 TEL: (450) 641-2440 FAX: (450) 449-4908 PRESS RELEASE First quarter ended March 31, 2013 Sales at $422 million and adjusted earnings at $7 million

More information

For Immediate Release MERCER INTERNATIONAL INC. REPORTS STRONG 2015 THIRD QUARTER RESULTS ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.

For Immediate Release MERCER INTERNATIONAL INC. REPORTS STRONG 2015 THIRD QUARTER RESULTS ANNOUNCES QUARTERLY CASH DIVIDEND OF $0. For Immediate Release MERCER INTERNATIONAL INC. REPORTS STRONG 2015 THIRD QUARTER RESULTS ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.115 NEW YORK, NY, October 29, 2015 - Mercer International Inc. (Nasdaq:

More information

August 11, 2015. Q2 2015 Earnings Presentation

August 11, 2015. Q2 2015 Earnings Presentation August 11, 2015 fa Q2 2015 Earnings Presentation Disclaimer These slides contain (and the accompanying oral discussion will contain) forward looking statements. All statements other than statements of

More information

Net attributable income totaled 64.7million in first-half 2015 compared with 69.0 million in firsthalf

Net attributable income totaled 64.7million in first-half 2015 compared with 69.0 million in firsthalf HALF-YEAR RESULTS 2015 H1 2015: FURTHER STRONG GROWTH FOR COMMUNICATION AND SHIPPING SOLUTIONS Sales up 10.4%, or -1.1% organically 1 CSS activities: organic growth of 16.0% Current operating margin 2

More information

Centrale del Latte di Torino & C. S.p.A. - CLT Group Via Filadelfia 220 10137 Turin - Italy Tel. +39 011 3240200 - Fax +39 011 3240300 e-mail: posta

Centrale del Latte di Torino & C. S.p.A. - CLT Group Via Filadelfia 220 10137 Turin - Italy Tel. +39 011 3240200 - Fax +39 011 3240300 e-mail: posta Centrale del Latte di Torino & C. S.p.A. - CLT Group Via Filadelfia 220 10137 Turin - Italy Tel. +39 011 3240200 - Fax +39 011 3240300 e-mail: posta @centralelatte.torino.it www.centralelatte.torino.it

More information

Interim financial report for the period 1 January to 30 September 2011

Interim financial report for the period 1 January to 30 September 2011 Company announcement no. 11/ 18 November Page 1 of 9 Interim financial report for the period 1 January to 30 September Highlights Results improved in the third quarter with a gross profit of USD 8 million

More information

I will now give you an overview of our third quarter financial results using the document titled Consolidated Results of Operations.

I will now give you an overview of our third quarter financial results using the document titled Consolidated Results of Operations. I will now give you an overview of our third quarter financial results using the document titled Consolidated Results of Operations. Please turn to page two. 1 For the nine months to December, net revenue

More information

INTERIM REPORT ON FIRST QUARTER OF 2015 201fehlungBild austauschen) Q1

INTERIM REPORT ON FIRST QUARTER OF 2015 201fehlungBild austauschen) Q1 Interim Report Q1 2015 INTERIM REPORT ON FIRST QUARTER OF 2015 201fehlungBild austauschen) Q1 1 Interim Report Q1 2015 2 Letter from the Management Board Dear Shareholders, Ladies and Gentlemen, These

More information

Waste Management Announces Second Quarter Earnings

Waste Management Announces Second Quarter Earnings FOR IMMEDIATE RELEASE Waste Management Announces Second Quarter Earnings Collection and Disposal Income from Operations Grows 3.4% HOUSTON July 26, 2012 Waste Management, Inc. (NYSE: WM) today announced

More information

EU Supply Plc ( EU Supply, the Company or the Group ) Interim results for the six months ended 30 June 2015

EU Supply Plc ( EU Supply, the Company or the Group ) Interim results for the six months ended 30 June 2015 9 September EU Supply Plc ( EU Supply, the Company or the Group ) Interim results for the six months ended EU Supply, the e-procurement SaaS provider, is pleased to announce its unaudited interim results

More information

2014 Half-Year Results

2014 Half-Year Results 2014 Half-Year Results July 30, 2014 Amsterdam Nancy McKinstry Chief Executive Officer and Chairman Kevin Entricken Chief Financial Officer Forward-looking Statements This presentation contains forward-looking

More information

COMMENTS RELATIVE TO THE FORTH QUARTER OF THE YEAR 2006 BOARD OF DIRECTOR'S REPORT ON MANAGEMENT PERFORMANCE OF THE ENGINEERING GROUP

COMMENTS RELATIVE TO THE FORTH QUARTER OF THE YEAR 2006 BOARD OF DIRECTOR'S REPORT ON MANAGEMENT PERFORMANCE OF THE ENGINEERING GROUP ENGINEERING INGEGNERIA INFORMATICA SpA. ROME, Via San Martino della Battaglia, 56 THE UNDERSIGNED AND FULLY PAID UP SHARE CAPITAL IS EQUAL TO 31,875,000 TRADE REGISTER NO. 00967720285 ROME CHAMBERS OF

More information

Interim Management Report. for the Bolzoni Group

Interim Management Report. for the Bolzoni Group Interim Management Report for the Bolzoni Group at 31 March 2011 1 INDEX Corporate offices pg. 3 Group activity pg. 5 Group structure pg. 6 Comments of the Directors on the Company s performance pg. 7

More information

Logista Q Results. February 9, 2016

Logista Q Results. February 9, 2016 Logista Q1 2016 Results February 9, 2016 Logista reports Q1 2016 Results Logista announces today its First Quarter Results for 2016. Main highlights: Revenues growing by 2.3% Good performance of Economic

More information

PRESS RELEASE February 4, 2016 SIMPSON MANUFACTURING CO., INC. ANNOUNCES FOURTH QUARTER RESULTS

PRESS RELEASE February 4, 2016 SIMPSON MANUFACTURING CO., INC. ANNOUNCES FOURTH QUARTER RESULTS PRESS RELEASE February 4, 2016 SIMPSON MANUFACTURING CO., INC. ANNOUNCES FOURTH QUARTER RESULTS Pleasanton, CA - Simpson Manufacturing Co., Inc. (the Company ) (NYSE: SSD) today announced its fourth quarter

More information

UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2015

UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2015 BE SEMICONDUCTOR INDUSTRIES N.V. DUIVEN, THE NETHERLANDS UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2015 Contents Unaudited Condensed Interim Consolidated

More information

Gruppo MutuiOnline First Half 2011 Results. 11 th August 2011

Gruppo MutuiOnline First Half 2011 Results. 11 th August 2011 Gruppo MutuiOnline First Half 211 Results 11 th August 211 Disclaimer Certain statements contained herein are statements of future expectations and other forward-looking statements. These expectations

More information

February 2, 2016 Consolidated Financial Results for the Third Quarter of Fiscal Year 2015 (From April 1, 2015 to December 31, 2015) [Japan GAAP]

February 2, 2016 Consolidated Financial Results for the Third Quarter of Fiscal Year 2015 (From April 1, 2015 to December 31, 2015) [Japan GAAP] February 2, 2016 Consolidated Financial Results for the Third Quarter of Fiscal Year 2015 (From April 1, 2015 to December 31, 2015) [Japan GAAP] Company Name: Idemitsu Kosan Co.,Ltd. (URL http://www.idemitsu.com)

More information

PRESS RELEASE RELEASE DATE: February 24, 2015

PRESS RELEASE RELEASE DATE: February 24, 2015 5N Plus Inc. Reports Results for Quarter and Fiscal Year Ended December 31, 2014 PRESS RELEASE RELEASE DATE: February 24, 2015 Montreal, Québec, February 24, 2015 5N Plus Inc. (TSX:VNP), the leading producer

More information

Kurita Water Industries Reports Earnings for the First Half Ended September, 2004

Kurita Water Industries Reports Earnings for the First Half Ended September, 2004 FOR IMMEDIATE RELEASE Kurita Water Industries Reports Earnings for the First Half Ended September, Tokyo Japan November 4, Kurita Water Industries Ltd. (TSE Security Code 6370) announced revenue for the

More information

Summary of Consolidated Financial Statements for the Second Quarter of Fiscal Year Ending March 31, 2012 (Japanese GAAP)

Summary of Consolidated Financial Statements for the Second Quarter of Fiscal Year Ending March 31, 2012 (Japanese GAAP) This document is a translation of the Japanese financial statements and is not in conformity with accounting principles of the United States. Summary of Consolidated Financial Statements for the Second

More information

ATS AUTOMATION TOOLING SYSTEMS INC.

ATS AUTOMATION TOOLING SYSTEMS INC. Interim Consolidated Financial Statements For the period ended June 29, 2014 (Unaudited) (Condensed) Interim Consolidated Statements of Financial Position (in thousands of Canadian dollars unaudited) June

More information

Third Quarter 2015 Financial Highlights:

Third Quarter 2015 Financial Highlights: DISCOVERY COMMUNICATIONS REPORTS THIRD QUARTER 2015 RESULTS, INCREASES BUYBACK AUTHORIZATION BY $2 BILLION AND ANNOUNCES RESUMPTION OF SHARE REPURCHASES BEGINNING IN FOURTH QUARTER 2015 Third Quarter 2015

More information

WE ARE DEFINED BY OUR VALUES

WE ARE DEFINED BY OUR VALUES Q1 DATA GROUP LTD. Quarter One ended March 31, 2014 WE ARE DEFINED BY OUR VALUES Our success owes much to a set of corporate values which define and drive our culture. We will be innovative, indeed visionary,

More information

Intel Reports Second-Quarter Results

Intel Reports Second-Quarter Results Intel Corporation 2200 Mission College Blvd. Santa Clara, CA 95054-1549 CONTACTS: Mark Henninger Amy Kircos Investor Relations Media Relations 408-653-9944 480-552-8803 mark.h.henninger@intel.com amy.kircos@intel.com

More information

THE WAY TO MAKE IT. Results 2013 and Outlook 2014. Agenda. 26 March 2014. Results 2013. Focus and outlook 2014 Discussion

THE WAY TO MAKE IT. Results 2013 and Outlook 2014. Agenda. 26 March 2014. Results 2013. Focus and outlook 2014 Discussion Results 2013 and Outlook 2014 26 March 2014 26 March 2014 / Results 2013 and Outlook 2014 / 1 Agenda Results 2013 Operational performance Financial performance Focus and outlook 2014 Discussion 26 March

More information

Ahlers AG, Herford. ISIN DE0005009708 and DE0005009732 INTERIM REPORT

Ahlers AG, Herford. ISIN DE0005009708 and DE0005009732 INTERIM REPORT Ahlers AG, Herford ISIN DE0005009708 and DE0005009732 on the first nine months of fiscal 2005/06 (December 1, 2005, to August 31, 2006) BUSINESS DEVELOPMENT IN THE FIRST NINE MONTHS OF FISCAL 2005/06 According

More information

PRESS RELEASE THE BOARD OF DIRECTORS OF CAMFIN SPA APPROVES FINANCIAL STATEMENTS AS OF 30 JUNE 2010:

PRESS RELEASE THE BOARD OF DIRECTORS OF CAMFIN SPA APPROVES FINANCIAL STATEMENTS AS OF 30 JUNE 2010: CAMFIN PRESS RELEASE THE BOARD OF DIRECTORS OF CAMFIN SPA APPROVES FINANCIAL STATEMENTS AS OF 30 JUNE 2010: CONSOLIDATED NET INCOME 1.6 MILLION EUROS (22.7 MILLION EUROS IN THE FIRST HALF OF 2009 THANKS

More information

Revenue and income down, in line with expectations

Revenue and income down, in line with expectations Benetton Group Board of Directors approves the 2012 first quarter results Revenue and income down, in line with expectations Revenues 428 million, -5.5% against first quarter 2011 Gross operating profit

More information

For personal use only GALE PACIFIC LIMITED

For personal use only GALE PACIFIC LIMITED GALE PACIFIC LIMITED RESULTS FOR YEAR ENDED 30 JUNE 2013 FY13 Review FY13 FY12 FY11 A$M S A$M S % Variance A$M S Sales 120.0 110.5 9% 95.6 EBITDA 18.0 18.0 0% 15.8 EBIT 12.9 12.5 4% 9.9 NPAT 9.1 8.5 7%

More information

W.W. Grainger, Inc. First Quarter 2015 Results Page 1 of 9

W.W. Grainger, Inc. First Quarter 2015 Results Page 1 of 9 W.W. Grainger, Inc. First Quarter 2015 Results Page 1 of 9 News Release GRAINGER REPORTS RESULTS FOR THE 2015 FIRST QUARTER Revises 2015 Guidance Quarterly Summary Sales of $2.4 billion, up 2 percent Operating

More information

Makita Corporation. Consolidated Financial Results for the nine months ended December 31, 2007 (U.S. GAAP Financial Information)

Makita Corporation. Consolidated Financial Results for the nine months ended December 31, 2007 (U.S. GAAP Financial Information) Makita Corporation Consolidated Financial Results for the nine months ended (U.S. GAAP Financial Information) (English translation of "ZAIMU/GYOSEKI NO GAIKYO" originally issued in Japanese language) CONSOLIDATED

More information

LOTTOMATICA GROUP S.p.A.

LOTTOMATICA GROUP S.p.A. LOTTOMATICA GROUP S.p.A. INFORMATIONAL MEMORANDUM RELATING TO THE 2012-2016 STOCK ALLOCATION PLAN, PREPARED PURSUANT TO ARTICLE 84-BIS OF THE CONSOB RULES UNDER RESOLUTION NO. 11971 OF 14 MAY 1999, AS

More information

Press release first quarter figures 2010

Press release first quarter figures 2010 Press release first quarter figures 2010 VASTNED RETAIL REALISES DIRECT INVESTMENT RESULT OF 17.1 MILLION IN SPITE OF DIFFICULT LETTING MARKET; VALUE MOVEMENTS IN PROPERTY PORTFOLIO BACK INTO BLACK AFTER

More information

Full Year 2012 Results. Madrid, February 28 th, 2013

Full Year 2012 Results. Madrid, February 28 th, 2013 Full Year 2012 Results Madrid, February 28 th, 2013 Our progress in 2012 1. A new company identity and mission 2. A fully integrated organization 3. A strong plan going forward 4. Solid business and financial

More information

PRESS RELEASE. NOEMALIFE: The Board of Directors approved the Draft Financial Statements for the year ended as at 31 December 2012.

PRESS RELEASE. NOEMALIFE: The Board of Directors approved the Draft Financial Statements for the year ended as at 31 December 2012. PRESS RELEASE NOEMALIFE: The Board of Directors approved the Draft Financial Statements for the year ended as at 31 December 2012. Consolidated operating revenues of EUR 67.5 million, +39% over 2011. EBITDA*

More information

Currency-neutral sales growth Earnings hurt by change in production and strong Swiss franc

Currency-neutral sales growth Earnings hurt by change in production and strong Swiss franc Press release Currency-neutral sales growth Earnings hurt by change in production and strong Swiss franc Sales expressed in Group currency down on first half of 2014 as expected; increase of 2 percent

More information

COTT ANNOUNCES FIRST QUARTER 2012 RESULTS AND SHARE REPURCHASE PROGRAM FOR UP TO $35 MILLION IN COMMON SHARES

COTT ANNOUNCES FIRST QUARTER 2012 RESULTS AND SHARE REPURCHASE PROGRAM FOR UP TO $35 MILLION IN COMMON SHARES CONTACT: Michael C. Massi Investor Relations Tel: (813) 313-1786 Investor.relations@cott.com COTT ANNOUNCES FIRST QUARTER 2012 RESULTS AND SHARE REPURCHASE PROGRAM FOR UP TO $35 MILLION IN COMMON SHARES

More information

Sample Due Diligence Checklist

Sample Due Diligence Checklist Sample Due Diligence Checklist 01.0. CORPORATE ORGANIZATION AND HISTORY 1.1. - Overview of corporate legal structure, banking relationships (other than transaction financing), organizational charts and

More information

PARMALAT INTERNAL DEALING CODE OF CONDUCT

PARMALAT INTERNAL DEALING CODE OF CONDUCT PARMALAT INTERNAL DEALING CODE OF CONDUCT CONTENTS 1. Foreword 2. Definitions 3. Disclosures Required of Significant Parties 4. Reporting of Transactions to the Consob and the Market by the Compliance

More information

Second quarter 2015 results 1

Second quarter 2015 results 1 Second quarter results 1 Luxembourg, July 29, Highlights Health and Safety frequency rate 2 of 0.8x in Q2 compared to 1.3x in Q1. Shipments of 486 thousand tonnes in Q2 compared to 469 thousand tonnes

More information

INFORMATION DOCUMENT PERTAINING TO COMPENSATION PLANS BASED ON FINANCIAL INSTRUMENTS

INFORMATION DOCUMENT PERTAINING TO COMPENSATION PLANS BASED ON FINANCIAL INSTRUMENTS S.p.A. INFORMATION DOCUMENT PERTAINING TO COMPENSATION PLANS BASED ON FINANCIAL INSTRUMENTS (2016 Plan) (pursuant to Article 114 Bis of the CFA and Article 84 Bis of the Consob Issuers Regulations) Document

More information

ASML - Summary IFRS Consolidated Statement of Profit or Loss 1,2

ASML - Summary IFRS Consolidated Statement of Profit or Loss 1,2 ASML - Summary IFRS Consolidated Statement of Profit or Loss 1,2 Three months ended, Nine months ended, Sep 28, Sep 27, Sep 28, Sep 27, 2014 2015 2014 2015 Net system sales 884.5 975.3 3,157.5 3,356.3

More information

Management Discussion and Analysis of Financial Position and Operating Results

Management Discussion and Analysis of Financial Position and Operating Results Management Discussion and Analysis of Financial Position and Operating Results The purpose of this analysis is to provide the reader with an overview of how the financial position of Héroux-Devtek Inc.

More information

compared to the fourth quarter of 2006, the third quarter of 2007, and to the year ended

compared to the fourth quarter of 2006, the third quarter of 2007, and to the year ended FOR IMMEDIATE RELEASE CaNT ACT: Susan Conway Director of Investor Relations Cognex Corporation Phone: (508) 650-3353 Email: susan. conway((i).coanex. com COGNEX CORPORATION ANNOUNCES FOURTH QUARTER RESULTS

More information

PRESS RELEASE DANIELI GROUP

PRESS RELEASE DANIELI GROUP DANIELI & C. OFFICINE MECCANICHE S.p.A. Buttrio (UD) via Nazionale n. 41 Fully paid-up share capital of euro 81,304,566 Registration Number with the Register of Companies of Udine, tax number and VAT registration

More information

Commerzbank German Investment Seminar. Dr. Jürgen Köhler, CEO New York. January 2016

Commerzbank German Investment Seminar. Dr. Jürgen Köhler, CEO New York. January 2016 SGL Group s Strategic Realignment Commerzbank German Investment Seminar Dr. Jürgen Köhler, CEO New York January 2016 Transformation of SGL Group. Guided by clearly defined targets (Sept. 2014) Capital

More information

INFORMATION DOCUMENT ABOUT TRANSACTIONS OF GREATER IMPORTANCE WITH RELATED PARTIES

INFORMATION DOCUMENT ABOUT TRANSACTIONS OF GREATER IMPORTANCE WITH RELATED PARTIES Corporation with registered office in Via Terraglio 63, 30174 Mestre, Venice Tax code and Company Registration no. Venice 02505630109 VAT registration no. 02992620274 REA number: VE - 0247118 Share Capital

More information

FINANCIAL REPORT H1 2014

FINANCIAL REPORT H1 2014 FINANCIAL REPORT H1 2014 HIGH SPEED BY PASSION 02_Key Figures 03_Group Status Report 05_Consolidated Financial Statements 10_Notes 11_Declaration of the Legal Representatives 02 PANKL KEY FIGURES EARNING

More information

Consolidated Results for the First Quarter of the Fiscal Year Ending March 20, 2016

Consolidated Results for the First Quarter of the Fiscal Year Ending March 20, 2016 Consolidated Results for the First Quarter of the Fiscal Year Ending March 20, 2016 [Japan GAAP] July 21, 2015 Listed company name: YASKAWA Electric Corporation http://www.yaskawa.co.jp/en/ Representative:

More information

STAR CONFERENCE 2015 Milan

STAR CONFERENCE 2015 Milan STAR CONFERENCE 2015 Milan Elica Corporation Today N#1 Player Worldwide in Hoods 2014 Turnover 391.9 M > 3500 Employees 2 19 Mln Hoods + Motors Cooking Net Sales: Own Brand 41% Client Brand 59 % 2 & 3

More information